ABALONE BIO, INC.

ABALONE BIO, INC. is a biotechnology firm based in Emeryville, California, with a focus on advanced life sciences research and development. While specific contract details are not available to infer past performance, the company’s name and location suggest specialized expertise in molecular biology, bioinformatics, and translational research—areas commonly associated with innovation in genomics, protein engineering, and diagnostic platform development. The firm likely provides technical services supporting early-stage therapeutic discovery, assay design, or high-throughput screening technologies, with an emphasis on scalable biological data analysis and laboratory automation systems. Its operational structure as a 2L entity indicates a small, agile organization potentially engaged in contract research or government-sponsored R&D initiatives. No agency relationships or award history are discernible from available data, preventing identification of specific federal partners or programmatic focus areas. Similarly, no NAICS codes or certifications are listed, so market positioning within defined federal procurement categories cannot be determined. The company does not hold any known government certifications such as 8(a), HUBZone, or SDVOSB status. Geographically, ABALONE BIO, INC. is situated in a major biotech hub, suggesting proximity to academic research institutions, venture-backed life science startups, and federal research labs. Its business profile reflects a lean, technically driven enterprise likely serving niche segments within the biomedical R&D ecosystem, with capabilities centered on experimental design, data-driven biological modeling, and laboratory informatics. Without documented contracts, its government market footprint remains undefined, but its location and nomenclature imply alignment with federally funded innovation initiatives in precision medicine and biosecurity.